Herpes simplex virus type 1 and Alzheimer’s disease: link and potential impact on treatment

References

• World Alzheimer Report. 2018. The state of art of dementia research: new frontiers. Alzheimer’s disease international. Avalaible from: https://www.alz.co.uk/research/WorldAlzheimerReport2018.pdf?2
   Google Scholar
• McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7:263–269.
   PubMed Web of Science ®Google Scholar
• Sperling RA, Aisen PS, Beckett LA, et al. Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Demen. 2011;7:280–292.
   PubMed Web of Science ®Google Scholar
• Kumar A, Singh A, Ekavali N. A review on Alzheimer’s disease pathophysiology and its management: an update. Pharmacol Rep. 2015;67:195–203.
   PubMed Web of Science ®Google Scholar
• Itzhaki RF, Lathe R, Balin BJ, et al. Microbes and Alzheimer’s disease. J Alzheimers Dis. 2016;51(4):979–984.
   PubMed Web of Science ®Google Scholar
• Ball MJ. Limbic predilection in Alzheimer dementia: is reactivated herpesvirus involved? Can J Neurol Sci. 1982;9(3):303–306.
   PubMed Web of Science ®Google Scholar
• Davis LE, Johnson RT. An explanation for the localization of herpes simplex encephalitis? Ann Neurol. 1979;5:2–5.
   PubMed Web of Science ®Google Scholar
• Jamieson GA, Maitland NJ, Wilcock GK, et al. Latent herpes simplex virus type 1 in normal and Alzheimer’s disease brains. J Med Virol. 1991;33:224–227.
   PubMed Web of Science ®Google Scholar
• Itzhaki RF, Lin WR, Shang D, et al. Herpes simplex virus type 1 in brain and risk of Alzheimer’s disease. Lancet. 1997;349:241–244.
   PubMed Web of Science ®Google Scholar
• Itzhaki RF, Wozniak MA. Herpes simplex virus type 1 in Alzheimer’s disease: the enemy within. J Alzheimers Dis. 2008;13:393–405.
   PubMed Web of Science ®Google Scholar
• Walker DG, O’Kusky JR, McGeer PL. In situ hybridization analysis for herpes simplex virus nucleic acids in Alzheimer disease. Alzheimer Dis Assoc Disord. 1989;3:123–131.
   PubMedGoogle Scholar
• Olsson J, Lovheim H, Honkala E, et al. HSV presence in brains of individuals without dementia: the TASTY brain series. Dis Model Mech. 2016;9:1349–1355.
   PubMed Web of Science ®Google Scholar
• Baringer JR, Pisani P. Herpes simplex virus genomes in human nervous system tissue analyzed by polymerase chain reaction. Ann Neurol. 1994;36:823–829.
   PubMed Web of Science ®Google Scholar
• Readhead B, Haure-Mirande JV, Funk CC, et al. Multiscale analysis of independent Alzheimer’s cohorts finds disruption of molecular, genetic, and clinical networks by human herpesvirus. Neuron. 2018;99(1):64–82.e7.
   PubMed Web of Science ®Google Scholar
• Alonso R, Pisa D, Fernandez-Fernandez AM, et al. Infection of fungi and bacteria in brain tissue from elderly persons and patients with Alzheimer’s disease. Front Aging Neurosci. 2018;10:159.
   PubMed Web of Science ®Google Scholar
• Roizman B, Whitley RJ. An inquiry into the molecular basis of HSV latency and reactivation. Annu Rev Microbiol. 2013;67:355–374.
   PubMed Web of Science ®Google Scholar
• Whitley R, Kimberlin DW, Prober CG. Pathogenesis and disease. In: Human herpesviruses: biology, therapy, and immunoprophylaxis. Cambridge: Cambridge University Press; 2007:1–1410.
   Google Scholar
• World Health Organization. 2017. Herpes simplex virus. Avalaible from: http://www.who.int/mediacentre/factsheets/fs400/en/
   Google Scholar
• Looker KJ, Magaret AS, May MT, et al. Global and regional estimates of prevalent and incident herpes simplex virus type 1 infections in 2012. PLoS One. 2015;10(10):e0140765.
   PubMed Web of Science ®Google Scholar
• Roizman B, Campadelli-Fiume G. Alphaherpes viral genes and their functions. In: Immunoprophylaxis. Cambridge: Cambridge University Press; 2007. p. 6.
   Google Scholar
• Campadelli-Fiume G, Menotti L. Entry of alphaherpesviruses into the cell. In: human herpesviruses: biology, therapy, and immunoprophylaxis. Cambridge: Cambridge University Press; 2007:93–111.
   Google Scholar
• Kelly BJ, Fraefel C, Cunningham AL, et al. Functional roles of the tegument proteins of herpes simplex virus type 1. Virus Res. 2009;145(2):173–186.
   PubMed Web of Science ®Google Scholar
• Weed DJ, Nicola AV. Herpes simplex virus membrane fusion. Adv Anat Embryol Cell Biol. 2017;223:29–47.
   PubMed Web of Science ®Google Scholar
• Di Giovine P, Settembre EC, Bhargava AK, et al. A structure of herpes simplex virus glycoprotein D bound to the human receptor nectin-1. PLoS Patog. 2011;7:1–13.
   Web of Science ®Google Scholar
• Campadelli-Fiume G, Collins-McMillen D, Gianni T, et al. Integrins as herpesvirus receptors and mediators of the host signalosome. Annu Rev Virol. 2016;3(1):215–236.
   PubMedGoogle Scholar
• Dohner K, Binz A, Glass M, et al. Uncoupling uncoating of herpes simplex virus genomes from their nuclear import and gene expression. J Virol. 2011;85(9):4271–4283.
   PubMed Web of Science ®Google Scholar
• Roizman B, Zhou G, Du T. Checkpoints in productive and latent infections with herpes simplex virus 1: conceptualization of the issues. J Neurovirol. 2011;17(6):512–517.
   PubMed Web of Science ®Google Scholar
• Sampath P, Deluca NA. Binding of ICP4, TATA-binding protein, and RNA polymerase II to herpes simplex virus type 1 immediate-early, early, and late promoters in virus-infected cells. J Virol. 2008;82(5):2339–2349.
   PubMed Web of Science ®Google Scholar
• Sandri-Goldin RM. The many roles of the highly interactive HSV protein ICP27, a key regulator of infection. Future Microbiol. 2011;6(11):1261–1277.
   PubMed Web of Science ®Google Scholar
• Maruzuru Y, Shindo K, Liu Z, et al. Role of herpes simplex virus 1 immediate early protein ICP22 in viral nuclear egress. J Virol. 2014;88:7445–7454.
   PubMed Web of Science ®Google Scholar
• Herbring V, Baucker A, Trowitzsch S, et al. A dual inhibition mechanism of herpesviral ICP47 arresting a conformationally thermostable TAP complex. Sci Rep. 2016;6:36907.
   PubMed Web of Science ®Google Scholar
• Gu H. Infected cell protein 0 functional domains and their coordination in herpes simplex virus replication. World J Virol. 2016;5(1):1–13.
   PubMedGoogle Scholar
• Miranda-Saksena M, Denes CE, Diefenbach RJ, et al. Infection and transport of herpes simplex virus type 1 in neurons: role of the cytoskeleton. Viruses. 2018;10(2).
   Web of Science ®Google Scholar
• Koyuncu OO, Hogue IB, Enquist LW. Virus infections in the nervous system. Cell Host Microbe. 2013;13(4):379–393.
   PubMed Web of Science ®Google Scholar
• Bloom DC, Giordani NV, Kwiatkowski DL. Epigenetic regulation of latent HSV-1 gene expression. Biochim Biophys Acta. 2010;1799:246–256.
   PubMed Web of Science ®Google Scholar
• Carpenter D, Hsiang C, Brown DJ, et al. Stable cell lines expressing high levels of the herpes simplex virus type 1 LAT are refractory to caspase 3 activation and DNA laddering following cold shock induced apoptosis. Virology. 2007;369(1):12–18.
   PubMed Web of Science ®Google Scholar
• Valyi-Nagy T, Deshmane S, Dillner A, et al. Induction of cellular transcription factors in trigeminal ganglia of mice by corneal scarification, herpes simplex virus type 1 infection, and explantation of trigeminal ganglia. J Virol. 1991;65:4142–4152.
   PubMed Web of Science ®Google Scholar
• Miranda-Saksena M, Boadle RA, Aggarwal A, et al. Herpes simplex virus utilizes the large secretory vesicle pathway for anterograde transport of tegument and envelope proteins and for viral exocytosis from growth cones of human fetal axons. J Virol. 2009;83(7):3187–3199.
   PubMed Web of Science ®Google Scholar
• Nishiyama Y. Herpes simplex virus gene products: the accessories reflect her lifestyle well. Rev Med Virol. 2004;14(1):33–46.
   PubMed Web of Science ®Google Scholar
• Tognarelli EI, Palomino TF, Corrales N, et al. Herpes simplex virus evasion of early host antiviral responses. Front Cell Infect Microbiol. 2019;9:127.
   PubMed Web of Science ®Google Scholar
• Carpenter D, Hsiang C, Jiang X, et al. The herpes simplex virus type 1 (HSV-1) latency-associated transcript (LAT) protects cells against cold-shock-induced apoptosis by maintaining phosphorylation of protein kinase B (AKT). J Neurovirol. 2015;21(5):568–575.
   PubMed Web of Science ®Google Scholar
• Shen W, Sa E Silva M, Jaber T, et al. Two small RNAs encoded within the first 1.5 kilobases of the herpes simplex virus type 1 latency-associated transcript can inhibit productive infection and cooperate to inhibit apoptosis. J Virol. 2009;83:9131–9139.
   PubMed Web of Science ®Google Scholar
• Kato A, Kawaguchi Y. Us3 protein kinase encoded by HSV: the precise function and mechanism on viral life cycle. Adv Exp Med Biol. 2018;1045:45–62.
   PubMed Web of Science ®Google Scholar
• Benetti L, Roizman B. Herpes simplex virus protein kinase US3 activates and functionally overlaps protein kinase A to block apoptosis. Proc Natl Acad Sci U S A. 2004;101(25):9411–9416.
   PubMed Web of Science ®Google Scholar
• Benetti L, Roizman B. In transduced cells, the US3 protein kinase of herpes simplex virus 1 precludes activation and induction of apoptosis by transfected procaspase 3. J Virol. 2007;81(19):10242–10248.
   PubMed Web of Science ®Google Scholar
• Jerome KR, Fox R, Chen Z, et al. Herpes simplex virus inhibits apoptosis through the action of two genes, Us5 and Us3. J Virol. 1999;73(11):8950–8957.
   PubMed Web of Science ®Google Scholar
• Jerome KR, Chen Z, Lang R, et al. HSV and glycoprotein J inhibit caspase activation and apoptosis induced by granzyme B or Fas. J Immunol. 2001;167(7):3928–3935.
   PubMed Web of Science ®Google Scholar
• You Y, Cheng AC, Wang MS, et al. The suppression of apoptosis by α-herpesvirus. Cell Death Dis. 2017;8(4):e2749.
   PubMedGoogle Scholar
• Yu X, He S. The interplay between human herpes simplex virus infection and the apoptosis and necroptosis cell death pathways. Virol J. 2016;13:77.
   PubMed Web of Science ®Google Scholar
• Hagglund R, Munger J, Poon AP, et al. U(S)3 protein kinase of herpes simplex virus 1 blocks caspase 3 activation induced by the products of U(S)1.5 and U(L)13 genes and modulates expression of transduced U(S)1.5 open reading frame in a cell type-specific manner. J Virol. 2002;76(2):743–754.
   PubMed Web of Science ®Google Scholar
• Ma Y, He B. Recognition of herpes simplex viruses: toll-like receptors and beyond. J Mol Biol. 2014;426(6):1133–1147.
   PubMed Web of Science ®Google Scholar
• Zhang SY, Jouanguy E, Ugolini S, et al. TLR3 deficiency in patients with herpes simplex encephalitis. Science. 2007;317:1522–1527.
   PubMed Web of Science ®Google Scholar
• Johnson KE, Chikoti L, Chandran B. Herpes simplex virus 1 infection induces activation and subsequent inhibition of the IFI16 and NLRP3 inflammasomes. J Virol. 2013;87:5005–5018.
   PubMed Web of Science ®Google Scholar
• Veeranki S, Choubey D. Interferon-inducible p200-family protein IFI16, an innate immune sensor for cytosolic and nuclear double-stranded DNA: regulation of subcellular localization. Mol Immunol. 2012;49:567–571.
   PubMed Web of Science ®Google Scholar
• Johnson KE, Bottero V, Flaherty S, et al. IFI16 restricts HSV-1 replication by accumulating on the hsv-1 genome, repressing HSV-1gene expression, and directly or indirectly modulating histone modifications. PLoS Pathog. 2014;10(11):e1004503.
   PubMed Web of Science ®Google Scholar
• Zhang J, Liu H, Wei B. Immune response of T cells during herpes simplex virus type 1 (HSV-1) infection. J Zhejiang Univ Sci B. 2017;18(4):277–288.
   PubMed Web of Science ®Google Scholar
• Wu X, Wu P, Shen Y, et al. CD8(+) resident memory T cells and viral infection. Front Immunol. 2018;9:2093.
   PubMedGoogle Scholar
• St Leger AJ, Hendricks RL. CD8+ T cells patrol HSV-1-infected trigeminal ganglia and prevent viral reactivation. J Neurovirol. 2011;17(6):528–534.
   PubMed Web of Science ®Google Scholar
• Kalantari-Dehaghi M, Chun S, Chentoufi AA, et al. Discovery of potential diagnostic and vaccine antigens in herpes simplex virus 1 and 2 by proteome-wide antibody profiling. J Virol. 2012;86(8):4328–4339.
   PubMed Web of Science ®Google Scholar
• Clementi N, Cappelletti F, Criscuolo E, et al. Role and potential therapeutic use of antibodies against herpetic infections. Clin Microbiol Infect. 2017;23(6):381–386.
   PubMed Web of Science ®Google Scholar
• Posavad CM, Remington M, Mueller DE, et al. Detailed characterization of T cell responses to herpes simplex virus-2 in immune seronegative persons. J Immunol. 2010;184:3250–3259.
   PubMed Web of Science ®Google Scholar
• Jing L, Laing KJ, Dong L, et al. Extensive CD4 and CD8 T cell cross-reactivity between alphaherpesviruses. J Immunol. 2016;196(5):2205–2218.
   PubMed Web of Science ®Google Scholar
• Johnston C, Gottlieb SL, Wald A. Status of vaccine research and development of vaccines for herpes simplex virus. Vaccine. 2016;34(26):2948–2952.
   PubMed Web of Science ®Google Scholar
• Su C, Zhan G, Zheng C. Evasion of host antiviral innate immunity by HSV-1, an update. Virol J. 2016;13:38.
   PubMed Web of Science ®Google Scholar
• Alexander DE, Leib DA. Xenophagy in herpes simplex virus replication and pathogenesis. Autophagy. 2008;4:101–103.
   PubMed Web of Science ®Google Scholar
• Mulvey M, Camarena V, Mohr I. Full resistance of herpes simplex virus type 1-infected primary human cells to alpha interferon require both the Us11 and γ134.5 gene products. J Virol. 2004;78:10193–10196.
   PubMed Web of Science ®Google Scholar
• Peng W, Henderson G, Inman M, et al. The locus encompassing the latency-associated transcript of herpes simplex virus type 1 interferes with and delays interferon expression in productively infected neuroblastoma cells and trigeminal ganglia of acutely infected mice. J Virol. 2005;79:6162–6171.
   PubMed Web of Science ®Google Scholar
• Imai T, Koyanagi N, Ogawa R, et al. Us3 kinase encoded by herpes simplex virus 1 mediates downregulation of cell surface major histocompatibility complex class I and evasion of CD8+ T cells. PLoS One. 2013;8:e72050.
   PubMed Web of Science ®Google Scholar
• Rao P, Pham HT, Kulkarni A, et al. Herpes simplex virus 1 glycoprotein B and US3 collaborate to inhibit CD1d antigen presentation and NKT cell function. J Virol. 2011;85(16):8093–8104.
   PubMed Web of Science ®Google Scholar
• Shives KD, Tyler KL, Beckham JD. Molecular mechanisms of neuroinflammation and injury during acute viral encephalitis. J Neuroimmunol. 2017;308:102–111.
   PubMed Web of Science ®Google Scholar
• Lokensgard JR, Hu S, Sheng W, et al. Robust expression of TNF-α, IL-1β, RANTES, and IP-10 by human microglial cells during nonproductive infection with herpes simplex virus. J Neurovirol. 2001;7:208–219.
   PubMed Web of Science ®Google Scholar
• Nicoll MP, Proenca JT, Efstathiou S. The molecular basis of herpes simplex virus latency. FEMS Microbiol Rev. 2012;26:684–705.
   Google Scholar
• Stowe RP, Peek MK, Cutchin MP, et al. Reactivation of herpes simplex virus type 1 is associated with cytomegalovirus and age. J Med Virol. 2012;84(11):1797–1802.
   PubMed Web of Science ®Google Scholar
• Martin C, Aguila B, Araya P, et al. Inflammatory and neurodegeneration markers during asymptomatic HSV-1 reactivation. J Alzheimers Dis. 2014;39:849–859.
   PubMed Web of Science ®Google Scholar
• Michael BD, Griffiths MJ, Granerod J, et al. The interleukin-1 balance during encephalitis is associated with clinical severity, blood-brain barrier permeability, neuroimaging changes, and disease outcome. J Infect Dis. 2016;213:1651–1660.
   PubMed Web of Science ®Google Scholar
• Aurelius E, Andersson B, Forsgren M, et al. Cytokines and other markers of intrathecal immune response in patients with herpes simplex encephalitis. J Infect Dis. 1994;170:678–681.
   PubMed Web of Science ®Google Scholar
• Knickelbein JE, Khanna KM, Yee MB, et al. Noncytotoxic lytic granule-mediated CD8+ T cell inhibition of HSV-1 reactivation from neuronal latency. Science. 2008;322(5899):268–271.
   PubMed Web of Science ®Google Scholar
• Yu W, Geng S, Suo Y, et al. Critical role of regulatory T cells in the latency and stress-induced reactivation of HSV-1. Cell Rep. 2018;25:2379–2389.
   PubMed Web of Science ®Google Scholar
• Dervillez X, Qureshi H, Chentoufi AA, et al. Asymptomatic HLA-A*02:01-restricted epitopes from herpes simplex virus glycoprotein B preferentially recall polyfunctional CD8+ T cells from seropositive asymptomatic individuals and protect HLA transgenic mice against ocular herpes. J Immunol. 2013;191:5124–5138.
   PubMed Web of Science ®Google Scholar
• Saresella M, Marventano I, Calabrese E, et al. A complex proinflammatory role for peripheral monocytes in Alzheimer’s disease. J Alzheimers Dis. 2014;38(2):403–413.
   PubMed Web of Science ®Google Scholar
• Saresella M, La Rosa F, Piancone F, et al. The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer’s disease. Mol Neurodegener. 2016;11:23.
   PubMed Web of Science ®Google Scholar
• Togo T, Akiyama H, Iseki E, et al. Occurrence of T cells in the brain of Alzheimer’s disease and other neurological diseases. J Neuroimmunol. 2002;124:83–92.
   PubMed Web of Science ®Google Scholar
• De Chiara G, Piacentini R, Fabiani M, et al. Recurrent herpes simplex virus-1 infection induces hallmarks of neurodegeneration and cognitive deficits in mice. PLoS Pathog. 2019;15(3):e1007617.
   PubMed Web of Science ®Google Scholar
• Agostini S, Mancuso R, Baglio F, et al. A protective role for herpes simplex virus type-1-specific humoral immunity in Alzheimer’s disease. Expert Rev Anti Infect Ther. 2017;15(2):89–91.
   PubMed Web of Science ®Google Scholar
• Letenneur L, Peres K, Fleury H, et al. Seropositivity to herpes simplex virus antibodies and risk of Alzheimer’s disease: a population-based cohort study. PLoS One. 2008;3(11):e3637.
   PubMed Web of Science ®Google Scholar
• Mancuso R, Baglio F, Cabinio M, et al. Titers of herpes simplex virus type 1 antibodies positively correlate with grey matter volume in Alzheimer’s disease. J Alzheimers Dis. 2014;38:741–745.
   PubMed Web of Science ®Google Scholar
• Mancuso R, Baglio F, Agostini S, et al. Relationship between herpes simplex virus-1-specific antibody titers and cortical brain damage in Alzheimer’s disease and amnestic mild cognitive impairment. Front Aging Neurosci. 2014;6:285.
   PubMed Web of Science ®Google Scholar
• Agostini S, Mancuso R, Baglio F, et al. Lack of evidence for a role of HHV-6 in the pathogenesis of Alzheimer’s disease. J Alzheimers Dis. 2015;49(1):229–235.
   Web of Science ®Google Scholar
• Dorshkind K, Montecino-Rodriguez E, Signer RA. The ageing immune system: is it ever too old to become young again? Nat Rev Immunol. 2009;9(1):57–62.
   PubMed Web of Science ®Google Scholar
• Montagne A, Barnes SR, Sweeney MD, et al. Blood-brain barrier breakdown in the aging human hippocampus. Neuron. 2015;85(2):296–302.
   PubMed Web of Science ®Google Scholar
• Kobayashi N, Nagata T, Shinagawa S, et al. Increase in the IgG avidity index due to herpes simplex virus type 1 reactivation and its relationship with cognitive function in amnestic mild cognitive impairment and Alzheimer’s disease. Biochem Biophys Res Commun. 2013;430(3):907–911.
   PubMed Web of Science ®Google Scholar
• Agostini S, Mancuso R, Baglio F, et al. High avidity HSV-1 antibodies correlate with absence of amnestic mild cognitive impairment conversion to Alzheimer’s disease. Brain Behav Immun. 2016;58:254–260.
   PubMed Web of Science ®Google Scholar
• Agostini S, Mancuso R, Hernis A, et al. HSV-1-specific IgG subclasses distribution and serum neutralizing activity in Alzheimer’s disease and in mild cognitive impairment. J Alzheimers Dis. 2018;63(1):131–138.
   PubMed Web of Science ®Google Scholar
• Vidarsson G, Dekkers G, Rispens T. IgG subclasses and allotypes: from structured to effector functions. Front Immunol. 2014;5:520.
   PubMed Web of Science ®Google Scholar
• Dubin G, Socolof E, Frank I, et al. Herpes simplex virus type 1 Fc receptor protects infected cells form antibody-dependent cellular cytotoxicity. J Virol. 1991;65:7046–7050.
   PubMed Web of Science ®Google Scholar
• Agrawal P, Nawadkar R, Ojha H, et al. Complement evasion strategies of viruses: an overview. Front Microbiol. 2017;8:1117.
   PubMed Web of Science ®Google Scholar
• Johansson PJ, Ota T, Tsuchiya N, et al. Studies of protein A and herpes simplex virus-1 induced FC-gamma binding specifities. Different binding patterns for IgG3 from caucasian and oriental subjects. Immunology. 1994;83:631–638.
   PubMed Web of Science ®Google Scholar
• Iijima N, Iwasaki A. Access of protective antiviral antibody to neuronal tissues requires CD4 T-cell help. Nature. 2016;533(7604):552–556.
   PubMed Web of Science ®Google Scholar
• Carbone I, Lazzarotto T, Ianni M, et al. Herpes virus in Alzheimer’s disease: relation to progression of the disease. Neurobiol Aging. 2014;35:122–129.
   PubMed Web of Science ®Google Scholar
• Mattson MP. Pathways towards and away from Alzheimer’s disease. Nature. 2004;430(7000):631–639.
   PubMed Web of Science ®Google Scholar
• Wozniak MA, Itzhaki RF, Shipley SJ, et al. Herpes simplex virus infection causes cellular β-amyloid accumulation and secretase upregulation. Neurosci Lett. 2007;429:95–100.
   PubMed Web of Science ®Google Scholar
• De Chiara G, Marcocci ME, Civitelli L, et al. APP processing induced by herpes simplex virus type 1 (HSV-1) yelds several APP fragments in human and rat neuronal cells. PloS One. 2010;5:e13989.
   PubMed Web of Science ®Google Scholar
• Piacentini R, Civitelli L, Ripoli C, et al. HSV-1 promotes Ca2+-mediated APP phosphorylation and Aβ accumulation in rat cortical neurons. Neurbiol Aging. 2011;32:2323.e13–2323–e26.
   PubMed Web of Science ®Google Scholar
• Lopez JR, Lyckman A, Oddo S, et al. Increased intraneuronal resting [Ca2+] in adult Alzheimer’s disease mice. J Neurochem. 2008;105:262–271.
   PubMed Web of Science ®Google Scholar
• Emilsson L, Saetre P, Jazin E. Alzheimer’s disease: mRNA expression profiles of multiple patients show alterations of genes involved with calcium signaling. Neurobiol Dis. 2006;21:618–625.
   PubMed Web of Science ®Google Scholar
• Cribbs DH, Azizeh BY, Cotman CW, et al. Fibril formation and neurotoxicity by a herpes simplex virus glycoprotein B fragment with homology to the Alzheimer’s A beta peptide. Biochemistry. 2000;39:5988–5994.
   PubMed Web of Science ®Google Scholar
• Benboudjema L, Mulvey M, Gao Y, et al. Association of the herpes simplex virus type 1 Us11 gene product with the cellular kinesin light-chain-related protein PA1 results in the redistribution of both polypeptides. J Virol. 2003;77:9192–9203.
   PubMed Web of Science ®Google Scholar
• Satpute-Krishnan P, DeGiorgis JA, Bearer EL. Fast anterograde transport of herpes simplex virus: role for the amyloid precursor protein of Alzheimer’s disease. Aging Cell. 2003;25:419–429.
   Google Scholar
• Robinson SR, Bishop GM. Abeta as bioflocculant: implications for the amyloid hypothesis of Alzheimer’s disease. Neurobiol Aging. 2002;23(6):1051–1072.
   PubMed Web of Science ®Google Scholar
• Bourgade K, Dupuis G, Frost EH, et al. Anti-viral properties of amyloid-β peptides. J Alzheimers Dis. 2016;54(3):859–878.
   PubMed Web of Science ®Google Scholar
• Spillantini MG, Goedert M. Tau pathology and neurodegeneration. Lancet Neurol. 2013;12(6):609–622.
   PubMed Web of Science ®Google Scholar
• Chun W, Johnson GV. The role of tau phosphorylation and cleavage in neuronal cell death. Front Biosci. 2007;12:733–756.
   PubMed Web of Science ®Google Scholar
• Zambrano A, Solis L, Salvadores N, et al. Neuronal cytoskeletal dynamic modification and neurodegeneration induced by infection with herpes simplex virus type 1. J Alzheimers Dis. 2008;14:259–269.
   PubMed Web of Science ®Google Scholar
• Alvarez G, Aldudo J, Alonso M, et al. Hepres simplex virus type 1 induces nuclear accumulation of hyperphosphorylated tau in neuronal cells. J Neurosci Res. 2012;90:1020–1029.
   PubMed Web of Science ®Google Scholar
• Wozniak MA, Frost AL, Itzhaki RF. Alzheimer’s disease-specific tau phosphorylation is induced by herpes simplex virus type 1. J Alzheimers Dis. 2009;16:341–350.
   PubMed Web of Science ®Google Scholar
• Nixohn RA. Autophagy, amyloidogenesis and Alzheimer’s disease. J Cell Sci. 2007;120:4081–4091.
   PubMed Web of Science ®Google Scholar
• Santana S, Bullido MJ, Recuero M, et al. Herpes simplex virus type 1 induces an incomplete autophagic response in human neuroblastoma cells. J Alzheimers Dis. 2012;30:815–831.
   PubMed Web of Science ®Google Scholar
• Santana S, Recuero M, Bullido MJ, et al. Herpes simplex virus type 1 induces the accumulation of intracellular β-amyloid in autophagic compartments and the inhibition of the non-amyloidogenic pathway in human neuroblastoma cells. Neurobiol Aging. 2012;33:430.e19–430.e33.
   Web of Science ®Google Scholar
• Scheff SW, Ansari MA, Mufson EJ. Oxidative stress and hippocamap synaptic protein levels in elderly cognivetively intact individuals with Alzheimer’s disease pathology. Neurobiol Aging. 2016;42:1–12.
   PubMedGoogle Scholar
• Nucci C, Palamara AT, Ciriolo MR, et al. Imbalance in corneal redox state during herpes simplex virus 1-induced keratitis in rabbits. Effectiveness of exogenous glutathione supply. Exp Eye Res. 2000;70:215–220.
   PubMed Web of Science ®Google Scholar
• Meyding-Lamadè U, Haas J, Lamadè W, et al. Herpes simplex virus encephalitis: long-term comparative study of viral load and the expression of immunologic nitric oxide synthase in mouse brain tissue. Neurosci Lett. 1998;244:9–12.
   PubMed Web of Science ®Google Scholar
• Santana S, Sastre I, Recuero M. Oxidative stress enhances neurodegeneration markers induced by herpes simplex virus type 1 infection in human neuroblastoma cells. PLoS One. 2013;8:e75842.
   PubMed Web of Science ®Google Scholar
• Elfawy HA, Das B. Crosstalk between mitochondrial dysfunction, oxidative stress, and age related neurodegenerative disease: etiologies and therapeutic strategies. Life Sci. 2019;218:165–184.
   PubMed Web of Science ®Google Scholar
• Kramer T, Enquist LW. Αherpesvirus infection disrupts mitochondrial transport in neurons. Cell Host Microbe. 2012;11:504–514.
   PubMed Web of Science ®Google Scholar
• Saffran HA, Pare JM, Corcoran JA, et al. Herpes simplex virus eliminates host mitochondrial DNA. EMBO Rep. 2007;8:188–193.
   PubMed Web of Science ®Google Scholar
• Huang Y, Mahley RW. Apolipoprotein E: structure and function in lipid metabolism, neurobiology, and Alzheimer’s diseases. Neurobiol Dis. 2014;72:3–12.
   PubMed Web of Science ®Google Scholar
• Guzman-Sanchez F, Valdivieso F, Burgos JS. Aging-related neurostructural, neuropathological, and behavioral changes associated with herpes simplex type 1 brain infection in mice. J Alzheimers Dis. 2012;30:779–790.
   PubMed Web of Science ®Google Scholar
• Itzhaki RF, Wozniak MA. Herpes simplex virus type 1, apolipoprotein E, and cholesterol: a dangerous liaison in Alzheimer’s disease and other disorders. Prog Lipid Res. 2006;45(1):73–90.
   PubMed Web of Science ®Google Scholar
• Lambert JC, Zelenika D, Hiltunen M, et al. Evidence of the association of BIN1 and PICALM with the AD risk in contrasting European population. Neurobiol Aging. 2011;32:756.e11–756.e15.
   Web of Science ®Google Scholar
• Porcellini E, Carbone I, Ianni M, et al. Alzheimer’s disease gene signature says: beware of brain viral infection. Immun Ageing. 2010;7:16.
   PubMedGoogle Scholar
• Tschopp J, Chonn A, Hertig S, et al. Clusterin, the human apolipoprotein and complement inhibitor, binds to complement C7, C8 beta, and the b domain of C9. J Immunol. 1993;151:2159–2165.
   PubMed Web of Science ®Google Scholar
• Humer HP, Wang Y, Garred P, et al. Herpes simplex virus glycoprotein C: molecular mimicry of complement regulatory proteins by a viral protein. Immunology. 1993;79:639–647.
   PubMed Web of Science ®Google Scholar
• Papassotiropoulos A, Lambert JC, Wavrant-De Vrieze F, et al. Cholesterol 25-hydroxylase on chromosome 10q is a susceptibility gene for sporadic Alzheimer’s disease. Neurodegener Dis. 2005;2:233–241.
   PubMed Web of Science ®Google Scholar
• Liu SY, Aliyari R, Chikere K, et al. Interferon-inducible cholesterol-25-hydroxylase broadly inhibits viral entry by production of 25-hydroxhycholesterol. Immunity. 2013;38:92–105.
   PubMed Web of Science ®Google Scholar
• Lathe R, Sapronova A, Kotelevtsev Y. Atherosclerosis and Alzheimer – disease with a common cause? Inflammation, oxysterols, vasculature. BMC Geriatr. 2014;14:36.
   PubMed Web of Science ®Google Scholar
• Costa AS, Agostini S, Guerini FR, et al. Modulation of immune responses to herpes simplex virus type 1 by IFNL3 and IRF7 polymorphisms: a study in Alzheimer’s disease. J Alzheimers Dis. 2017;60:1055–1063.
   PubMed Web of Science ®Google Scholar
• Rathore N, Ramani SR, Pantua H, et al. Paired immunoglobulin-like type 2 receptor alpha G78R variant alters ligand binding and confers protection to Alzheimer’s disease. PLoS Genet. 2018;14:e1007427.
   PubMed Web of Science ®Google Scholar
• Satoh T, Arii J, Suenaga T, et al. PILRalpha is a herpes simplex virus-1 entry coreceptor that associaters with glycoprotein B. Cell. 2008;132:935–944.
   PubMed Web of Science ®Google Scholar
• Arosio B, Trabattoni D, Galimberti L, et al. Interleukin-10 and interleukin-6 gene polymorphisms are risk factors for Alzheimer’s disease. Neurobiol Aging. 2004;25(8):1009–1015.
   PubMed Web of Science ®Google Scholar
• Sing R, Kumar A, Creery WD, et al. Dysregulated expression of IFN-gamma and IL-10 and impaired IFN-gamma-mediated responses at different disease stages in patients with genital herpes simplex virus-2 infection. Clin Exp Immunol. 2003;133(1):97–107.
   PubMed Web of Science ®Google Scholar
• Cummings JL, Zhong K. Repackaging FDA-approved drugs for degenerative diseases: promises and challenges. Expert Rev Clin Pharmacol. 2014;7(2):161–165.
   PubMed Web of Science ®Google Scholar
• Mielke MM, Leoutsakos JM, Corcoran CD, et al. Effects of food and drug administration-approved medications for Alzheimer’s disease on clinical progression. Alzheimers Dement. 2012;8(3):180–187.
   PubMed Web of Science ®Google Scholar
• Wozniak MA, Frost AL, Preston CM, et al. Antivirals reduce the formation of key Alzheimer’s disease molecules in cell cultures acutely infected with Herpes simplex virus type 1. PLoS One. 2011;6:e25152.
   PubMed Web of Science ®Google Scholar
• Tzeng NS, Chung CH, Lin FH, et al. Anti-herpetic medications and reduced risk of dementia in patients with herpes simplex virus infections – a nationwide, population – based cohort study in Taiwan. Neurotherapeutics. 2018;15(2):417–429.
   PubMed Web of Science ®Google Scholar
• Tsai MC, Cheng WL, Sheu JJ, et al. Increased risk of dementia following herpes zoster ophthalmicus. PLoS One. 2017;12(11):e0188490.
   PubMed Web of Science ®Google Scholar
• Chen VC, Wu SI, Hunag KY, et al. Herpes zoster and dementia: a nationwide population-based cohort study. J Clin Psychiatry. 2018;79(1).
   Web of Science ®Google Scholar
• Hussain G, Zhang L, Rasul A, et al. Role of plant-derived flavonoids and their mechanism in attenuation of Alzheimer’s and Parkinson’s diseases: an update of recent data. Molecules. 2018;23:814.
   Web of Science ®Google Scholar
• Zhang X, Wang G, Gurley EC, et al. Flavonoid apigenin inhibits lipopolysaccharide-induced inflammatory response through multiple mechanisms in macrophages. PLoS One. 2014;9(9):e107072.
   PubMed Web of Science ®Google Scholar
• Kim H, Bang OY, Jung MW, et al. Neuroprotective effects of estrogen against beta-amyloid toxicity are mediated by estrogen receptors in cultured neuronal cells. Neurosci Lett. 2001;302(1):58–62.
   PubMed Web of Science ®Google Scholar
• Wang H, Wang H, Cheng H, et al. Ameliorating effect of luteolin on memory impairment in an Alzheimer’s disease model. Mol Med Rep. 2016;13:4215–4220.
   PubMed Web of Science ®Google Scholar
• Choi Y, Choi JH, Lee JY, et al. Apigenin protects HT22 murine hippocampal neuronal cells against endoplasmic reticulum stress-induced apoptosis. Neurochem Int. 2010;57:143–152.
   PubMed Web of Science ®Google Scholar
• Du K, Liu M, Zhong X, et al. Epigallocatechin gallate reduces amyloid β-induced neurotoxicity via inhibiting endoplasmic reticulum stress-mediated apoptosis. Mol Nutr Food Res. 2018;62(8):e1700890.
   PubMed Web of Science ®Google Scholar
• Thummayot S, Tocharus C, Suksamrarn A, et al. Neuroprotective effects of cyanidin against Aβ-induced oxidative and ER stress in SK-N-SH cells. Neurochem Int. 2016;101:15–21.
   PubMed Web of Science ®Google Scholar
• Sohanaki H, Baluchnejadmojarad T, Nikbakht F, et al. Pelargonidin improves memory deficit in amyloid β25-35 rat model of Alzheimer’s disease by inhibition of glial activation, cholinesterase, and oxidative stress. Biomed Pharmacother. 2016;83:85–91.
   PubMed Web of Science ®Google Scholar
• Martin C, Leyton L, Arancibia Y, et al. Modulation of the AMPK/Sirt1 axis during neuronal infection by herpes simplex virus type 1. J Alzheimers Dis. 2014;42:301–312.
   PubMed Web of Science ®Google Scholar
• Salminen A, Hyttinen JM, Kaarniranta K. AMP-activated protein kinase inhibits NF-κB signaling and inflammation: impact on healthspan and lifespan. J Mol Med. 2011;89:667–676.
   PubMed Web of Science ®Google Scholar
• Faith SA, Sweet TJ, Bailey E, et al. Resveratrol suppresses nuclear factor-kappaB in herpes simplex virus infected cells. Antivir Res. 2006;72:242–251.
   PubMed Web of Science ®Google Scholar
• Araki T, Sasaki Y, Milbrandt J. Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration. Science. 2004;305:1010–1013.
   PubMed Web of Science ®Google Scholar
• Han YS, Zheng WH, Bastianetto S, et al. Neuropro-tective effects of resveratrol against beta-amyloid-induced neurotoxicity in rat hippocampal neurons: involvement of protein kinase C. Br J Pharmacol. 2004;141:997–1005.
   PubMed Web of Science ®Google Scholar
• Wang Q, Xu J, Rottinghaus GE, et al. Resveratrol protects against global cerebral ischemic injury in gerbils. Brain Res. 2002;958:439–447.
   PubMed Web of Science ®Google Scholar
• Sabogal-Guaqueta AM, Munoz-Manco JI, Ramirez-Pineda JR, et al. The flavonoid quercetin ameliorates Alzheimer’s disease pathology and protects cognitive and emotional function in aged triple transgenic Alzheimer’s disease model mice. Amsterdam: Elsevier Ltd; 2015.
   Google Scholar
• Scuderi C, Stecca C, Valenza M, et al. Palmitoylethanolamide controls reactive gliosis and exerts neuroprotective functions in a rat model of Alzheimer’s disease. Cell Death Dis. 2014;5:e1419.
   PubMed Web of Science ®Google Scholar
• Bronzuoli MR, Facchinetti R, Steardo L Jr, et al. Palmitoylethanolamide dampens reactive astrogliosis and improves neuronal trophic support in a triple transgenic model of Alzheimer’s disease: in vitro and in vivo evidence. Oxid Med Cell Longev. 2018;2018:4720532.
   PubMedGoogle Scholar
• Gill D, Glidden M, Dean R. Unusual side effect of acyclovir: bradycardia. Am J Emerg Med. 2017;35(3):525.e3–525.e4.
   Web of Science ®Google Scholar
• Raborn GW, Martel AY, Lassonde M, et al. Effective treatment of herpes simplex labialis with penciclovir cream: combined results of two trials. J Am Dent Assoc. 2002;133(3):303–309.
   PubMed Web of Science ®Google Scholar
• Andrei G, Topalis D, De Schutter T, et al. Insights into the mechanism of action of cidofovir and other acyclic nucleoside phosphonates against polyomaand papillomaviruses and non-viral induced neoplasia. Antiviral Res. 2015;114:21–46.
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Maruyama Y, Ohashi N, et al. Hypophosphatemia predicts a failure to recover from adefovir-related renal injury after dose reduction in lamivudine-resistant hepatitis B patients. Hepatol Res. 2017;47(12):1272–1281.
   PubMed Web of Science ®Google Scholar
• Sansone R, Ottaviani JI, Rodriguez-Mateos A, et al. Methylxanthines enhance the effects of cocoa flavanols on cardiovascular function: randomized, double-masked controlled studies. Am J Clin Nutr. 2017;105(2):352–360.
   PubMed Web of Science ®Google Scholar
• Qin Y, Zhai Q, Li Y, et al. Cyanidin-3-O-glucoside ameliorates diabetic nephropathy through regulation of glutathione pool. Biomed Pharmacother. 2018;103:1223–1230.
   PubMed Web of Science ®Google Scholar
• Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1984;1(8390):1311–1315.
   PubMed Web of Science ®Google Scholar
• Lovheim H, Norman T, Weidung B, et al. Herpes simplex virus, APOEε4, and cognitive decline in old age: results from the betula cohort. J Alzheimers Dis. 2019;67(1):211–220.
   PubMed Web of Science ®Google Scholar